Linneo Health and Phytocontrol Group have signed an exclusive medicinal cannabis clinical analysis collaboration agreement.
Prohibition Partners has released The Global Cannabis Report: 3rd Edition, which cites the UK and Germany as key European medical cannabis markets.
Michael Sassano, CEO of Somai Pharmaceuticals reflects on Q3 2022.
Astrasana Holding AG has secured a supply agreement.
Cantourage and CannFX have made the import.
AIM-listed cash shell company UK SPAC Plc has confirmed that the Financial Conduct Authority (FCA) has approved the prospectus of
Akanda will be exiting Africa following the unauthorised commencement of liquidation proceedings in respect of Bophelo Bio Science & Wellness.
GVB Biopharma, a 22nd Century Group company, has opened a new, strategically-located distribution facility in the Netherlands to support its
The launch takes place against the backdrop of legalisation efforts in Germany.
Akanda has stated it is ready to serve legal adult-use markets in Europe once established.
In collaboration with Solumedics AG, Astrasana Holding AG has initiated the first import of medical cannabis into Switzerland.
The European Industrial Hemp Association and German association Nutzhanf Netzwerk e. V. (NHN) have welcomed the publication of Germany’s legislation document, stating that “the witch-hunt on hemp could now finally come to an end.”
The company has signed a deal with a leading distributor in Norway.
Following the publication of a leaked report of draft legislation for recreational cannabis use in Germany, final plans have now been revealed by the Health Minister.
CBD of Denver has announced the signing of a letter of intent to work with German CBD and cannabis specialist Home of CBD as a
The plans focus on protection of health and minors.
The pair will be expanding their co-operation through the distribution of medical cannabis products.
Akanda CEO Tej Virk speaks to Cannabis Wealth about its new agreement to bring Cookies’ globally recognised genetics to the European market.
We won’t spam you
